SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-050289
Filing Date
2010-03-08
Accepted
2010-03-08 17:01:42
Documents
9
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1284635
2 WAIVER OF RIGHTS dex1025.htm EX-10.25 7106
3 EXCLUSIVE LICENSE AGREEMENT DATED OCTOBER 14, 2009 dex1026.htm EX-10.26 164415
4 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1535
5 CERTIFICATION PURSUANT TO RULE 15D 14 OF THE SECURITIES AND EXCHANGE ACT OF 1934 dex311.htm EX-31.1 9415
6 CERTIFICATION PURSUANT TO RULE 15D 14 OF THE SECURITIES AND EXCHANGE ACT OF 1934 dex312.htm EX-31.2 9669
7 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3630
8 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 3788
9 GRAPHIC g16608g82p37.jpg GRAPHIC 6995
  Complete submission text file 0001193125-10-050289.txt   1495382
Mailing Address 1300 SEAPORT BOULEVARD REDWOOD CITY CA 94063
Business Address 1300 SEAPORT BOULEVARD REDWOOD CITY CA 94063 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32979 | Film No.: 10664374
SIC: 2834 Pharmaceutical Preparations